Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

PaySign, Inc. (PAYS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3900+0.0700 (+5.30%)
At close: 04:00PM EDT
1.4000 +0.01 (+0.72%)
After hours: 06:08PM EDT
Advertisement
Sign in to post a message.
  • M
    Mike
    WTH down 92 pre. rutrow
  • W
    Wise
    Gonna pass $2 today! It hit Double Down support level 💰
    Bullish
  • J
    John
    SLIDELL, La. — Tuesdays she asked for the needle in her left arm, and one afternoon in late April, Christina Seal, 41, arrived at the clinic after work. The parking lot was almost full, as usual.

    She had been giving plasma for nearly six months, and she had a routine locked in place. Tuesdays and Thursdays. Two Sam’s Club protein shakes and an iron supplement a day to keep herself serviceable. Afterward, vitamin E oil on her skin to prevent needle scars. The routine had helped tame into normalcy what at first had felt so bizarre. “I never thought I would be in a position where I would have to sell my plasma to feed my children,” she would say later.

    This was where inflation had driven Seal. A month earlier, the Bureau of Labor Statistics had announced that prices had risen 8.5 percent over the past year, the largest annual jump since December 1981. Fuel, food and housing costs are higher than they have been in years. The financial strain has forced millions of households to collide against new limits and harder choices. Inflation has bent a million routines into new shapes.

    For Seal, it has meant that her 18-year teaching career alone can no longer provide for her two children, ages 15 and 12. It has meant feeding them peanut butter and jelly sandwiches, and explaining that she cannot afford the gas to drive both her son to boxing lessons and her daughter to volleyball. It has meant realizing there are few options for help.
    “I’ve applied for every government program that I can think of,” she said. “I don’t qualify for food stamps, I don’t qualify for any programs. For middle-class people like me, there are no programs.”

    Then, last fall, she found a possible solution. By donating plasma — the liquid element in human blood containing vital antibodies and proteins — twice a week each week, Seal could earn between $400 to $500 per month.

    That Tuesday at the plasma clinic, the waiting room was also nearly full.

    “$20 Fuel Bonus after every 4th Donation. Your wallet will love you and your car will ‘tank’ you,” read a poster on the wall.

    “When you refer a friend you earn a $50 Buddy Bonus!” another said.

    Seal had arrived with her boyfriend, Jason Boyer, 41. None of this was normal for him yet. It was only his second visit, and he mirrored her steps as she checked in at a video kiosk along the wall. Then they found seats, and bits of conversation drifted from the other rows.

    “I was going to this other one; they give you a hundred for each visit,” one person said.

    “I like here that the process is faster, the machine is quicker,” another explained.

    “Some places, the heavier you are, the more money you get,” a woman said.

    Seal left the center a few hours later with $50 added onto a debit card from the clinic. Thursday’s trip would add $80. Lately, she had started to experience excruciating stabs of pain in her abdomen. But her family needed those payments so badly that Seal forced herself to continue to those twice-weekly trips.
    ‘There is nothing left after I pay bills’
    https://www.washingtonpost.com/dc-md-va/2022/05/19/louisiana-teacher-plasma-inflation/
    A Louisiana teacher is among millions of Americans forced to make hard choices because of rising prices.
    A Louisiana teacher is among millions of Americans forced to make hard choices because of rising prices.
    www.washingtonpost.com
  • D
    Dylan P
    Glad I got out of this at 9.3 with a 5% loss. How Louis Navellier had this as a 100/100 rated company baffles me, but I suspect it was a "Nevada thing".
    Bearish
  • T
    THE-MAX
    Another power play in the works.. What's my name.. hehe THE MAX
  • M
    Mike
    someone knows something going down
  • M
    Mike
    OK 8 hrs and nothing, Mark is probably working on this quarter breakout earnings and future upside But Wise and Ward have been quiet 🤫
  • m
    mike
    Target .50 cent to $1.00 at best. NO EARNINGS. Invest in MO...18.6% per year for 50 years. Use your head.
  • c
    christopher
    Earnings out EOM today, right? Good luck fellow longs!
    Bullish
  • M
    Mike
    I have been nothing but out money on the investment can't sell it,down way too much.have to ride this #$%$ all the way
  • A
    Alex
    2.5$ option today?
  • m
    mike
    Est are now for negative earnings this year and .02 cents for next year from .11cents 4 months ago. The downtrend will continue IMO. .50 cents to $1.00 target., or maybe a reverse split. They should be ashamed of themselves.
    Bearish
  • E
    Eugene
    Should have sold before close. Are they giving away 2mil in stock and still not making a profit. Going to trade shows and investing in new offices without and good guidance for 2022.
  • M
    Mike
    wow met and tanked lol. Joe ward said Q2 or Q3 maybe
  • M
    Mike
    time to load up. lol right Joe
  • M
    Mike
    cricket's in here not even Joe Ward
  • M
    Mike
    Hello Mark Newcomer anybody
  • D
    Davi
    Paysign announced the appointment of Matt Lanford as Chief Product Officer.

    “Matt is a proven industry leader whose expertise will be invaluable as we expand our products digitally and add mobile wallet capabilities,” said Mark Newcomer, CEO, Paysign, Inc. “We are especially pleased to have Matt on board as Paysign continues to focus on implementing strategic priorities; delivering new, innovative solutions and providing the highest level of service to our clients and cardholders.”

    Lanford has over 30 years’ experience in the payments industry.
    Bullish
  • S
    Superbowl6
    The good news is volume is down to little more than half of what it was yesterday and that is good news.
    Don't watch the PPS to buy in watch the volume that is the key. When the volume is close to normal that means everybody that wants out is out and the traders are moving on.

    Everybody thinks the down grade by a no name analysis is the problem but I think its the shelf offering that is the dark cloud over the stock. You know they will use it and that will cause a reduction in the PPS.

    This stock is a take over company for somebody.
    Bottom line PAYS will be back on track by tomorrow . Good Luck !
  • m
    mrdecember123
    GREAT TIMING by management. Regular strong volume and positive buying interest has been simply stellar! All pps volatility will be well-sorted by earnings time most probably. Then mgmt delivers expected earnings- and voila! PAYS continues its rise. Regarding valuation(s), the STEADY ACCUMULATION AND CONSOLIDATION from mega volume suggests those in the institutional and/or bigger money know see actual UNDERVALUATION here still considering growth going forward- and no real competition plasma-wise. I don't know how mgmt will utilize the money exactly- but history here assures us mgmt is sober, competent, and growth-oriented. I try to always keep in mind with this PAYS gem that its one of the best bets on management going on nasdaq. Their record for the longest deserves an A+ grade. If they opted for this at this time. so be it. Know what you own, folks. My plan has always included the bulk of 2020 as my forward thinking for PAYS. How we get there is the interesting fun. buy, hold- and add at your leisure. Don't forget the unique niche PAYS fills in the plasma arena. Include in your overall hold-long thinking, too, the following. Like trump or hate trump- trump has PRIORITIZED the stock market as barometer for his administration. Not many presidents do that. For me- and this is NOT political, i feel trump has some of my back in any overall market risk. Just look how he tweet-manages crude, ffs! It's brand new. This kind of business-hands-on kind of president effecting market psychology so. I feel the trump winds at PAYS backs. I am but peon in the scheme of things. Do your own dd, folks. I still say mark newcomer and mgmt should be ceo and mgmt of the year for all nasdaq stocks. Great work, guys!
Advertisement
Advertisement